CLOXACILLIN - MEDO 500 MG

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Ingrédients actifs:

CLOXACILLIN AS SODIUM

Disponible depuis:

A.L. MEDI-MARKET LTD.

Code ATC:

J01CF02

forme pharmaceutique:

POWDER FOR SOLUTION FOR INJ/INF

Composition:

CLOXACILLIN AS SODIUM 500 MG/VIAL

Mode d'administration:

I.M, I.V

Type d'ordonnance:

Required

Fabriqué par:

MEDOCHEMIE LTD (FACTORY B), CYPRUS

Domaine thérapeutique:

CLOXACILLIN

indications thérapeutiques:

Cloxacillin is indicated for the treatment of sensitive staphylococcal infections:respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci.Cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.

Date de l'autorisation:

2020-01-16

Résumé des caractéristiques du produit

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Cloxacillin-Medo
500 mg, powder for solution for injection or infusion
Cloxacillin-Medo
1gr, powder for solution for injection or infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial contains 500mg or 1g of cloxacillin dry powder for solution
for injection or infusion
(as cloxacillin sodium).
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Powder for solution for injection or infusion
A white or almost white crystalline powder.
4.
CLINICAL PATICULARS
4.1.
THERAPEUTIC INDICATIONS
Cloxacillin
is
indicated
for
the
treatment
of
sensitive
staphylococcal
infections:
respiratory
infections,
otorhinolaryngologic infections, renal infections, urogenital
infections, neuro-meningeal infections, bone and
joint infections, endocarditis, and treatment of skin infections
caused by sensitive staphylococci and/or
streptococci. Cloxacillin is also indicated as preventive treatment of
postoperative infections in neurosurgery.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
DOSAGE IN PATIENTS WITH NORMAL RENAL AND HEPATIC FUNCTION:
Treatment of infections:
ADULTS
: 6 to 12 g / day, divided into 4-6 daily administrations
PAEDIATRIC POPULATION
: 100 to 200 mg / kg / day divided into 4-6 daily administrations,
without exceeding 12 g /
day.
Prevention of postoperative infections in adults:
the antibioprophylaxis must be of short duration, usually limited to
the intraoperative period, 24 hours, but never
more
than
48
hours:
- 2 g IV with induction of anesthesia,
- thereafter 1 g IV every 2 hours in case of prolonged intervention.
The duration of treatment should cover the entire duration of the
surgery until skin closure.
Method of administration
Cloxacillin-Medo injection is intended for intramuscular or
intravenous administration.
4.3
CONTRAINDICATIONS
Cloxacillin-Medo is
contraindicated
to
patients
hypersensitive
to
the
active
substance
or
other
penicillins,
cephalosporins, or penicillamine.
Cloxacillin- Medo should not be adminis
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit

Afficher l'historique des documents